Pseudotumor Cerebri Headache Ten Years Outcome
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Pseudotumor Cerebri. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Israel
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Headache Long Term Follow-up in Patients Who Suffered From PTCS During Their Childhood
Overview
Telephone interview on patient who suffered from PTC ten years ago regarding their headache status
Detailed description
The study will followup using existing medical data from patients previously diagnosed with Pseudotumor cerebri (PTC) using a telephone contact with patients diagnosed more than 10 years ago. After obtaining verbal consent, conducted interviews to collect information on their headaches and quality of life. Data related to PTC was be obtained from medical records. Demographic information was be collected using a questionnaire, the HIT-6 questionnaire will assess headache severity, and a quality of life questionnaire was be used.
Primary outcome measures
- headache outcome HIT-6 [Time frame: 5-10 years]
Secondary outcome measures (1)
- Quality of life (QOL) [Time frame: 5-10 years]
Eligibility criteria
Inclusion criteria
Patients who were diagnosed with PTC as children
\-
Exclusion criteria
Patients has other headache types other than PTC
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Israel · 1 center
- Bani Zion — Haifa
Publications
- Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985 Mar;5(1):55-6. No abstract available. PMID 3156890
- Kesler A, Bassan H. Pseudotumor cerebri - idiopathic intracranial hypertension in the pediatric population. Pediatr Endocrinol Rev. 2006 Jun;3(4):387-92. PMID 16816807
- Buchheit WA, Burton C, Haag B, Shaw D. Papilledema and idiopathic intracranial hypertension. N Engl J Med. 1969 Apr 24;280(17):938-42. doi: 10.1056/NEJM196904242801707. No abstract available. PMID 5775633
- Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002 Nov 26;59(10):1492-5. doi: 10.1212/01.wnl.0000029570.69134.1b. PMID 12455560
- Baker RS, Baumann RJ, Buncic JR. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol. 1989 Jan-Feb;5(1):5-11. doi: 10.1016/0887-8994(89)90002-7. PMID 2653341
- Couch R, Camfield PR, Tibbles JA. The changing picture of pseudotumor cerebri in children. Can J Neurol Sci. 1985 Feb;12(1):48-50. doi: 10.1017/s0317167100046588. PMID 3978475
- Dhiravibulya K, Ouvrier R, Johnston I, Procopis P, Antony J. Benign intracranial hypertension in childhood: a review of 23 patients. J Paediatr Child Health. 1991 Oct;27(5):304-7. doi: 10.1111/j.1440-1754.1991.tb02544.x. PMID 1931224
- Genizi J, Cymbrowicz M, Shemer-Meiri L, Ganz N, Sadeh A, Cohen R, Sharkia R, Zalan A, Abd El Karim Murad S, Ganelin-Cohen E, Mahajnah M. Long-term headaches in children with idiopathic intracranial hypertension-a 10 years follow-up. Front Pediatr. 2026 May 14;14:1726347. doi: 10.3389/fped.2026.1726347. eCollection 2026. PMID 42220989
Identifiers
NCT: NCT06581185 · BNAI ZION MEDICAL CENTER